Heron Therapeutics reported $90.54M in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Arrowhead Research ARWR:US $ 86.41M 5.18M
Eisai 4523:JP Y 258420M 24582M
Immunogen IMGN:US $ 437.66M 41.09M
Nektar Therapeutics NKTR:US $ 25.22M 28.8M
Omeros OMER:US $ 8.96M 91.84M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M